Patients with initially low- or intermediate-risk primary tumors will often have a high-risk recurrence before progressing to more advanced disease, whereas primary high-risk tumors typically show ...

Serum DR-70 levels are higher in bladder cancer patients, especially in muscle-invasive cases, indicating potential for diagnosis and staging. Current diagnostic methods for bladder cancer are ...

Park says patient-specific factors that influence his treatment selection include the presence of liver disease, ...

Discover the critical signs that indicate something may be wrong with your health. Experts advise on the importance of ...

The treatment of bladder cancer could see a major advancement thanks to an innovative drug delivery approach. This targeted ...

Stage 2 vaginal cancer involves spread beyond the vaginal wall but not to the pelvic sidewall, with symptoms like abnormal ...

ESMO 2025 bladder cancer highlights include results from KEYNOTE-905/EV-303, RC48-C016, and IMvigor011 studies.

Throughout October, CURE highlighted research developments and evolving treatment strategies that continue to shape cancer ...

HAMLET BioPharma, a clinical-stage biopharmaceutical company advancing targeted oncological and other therapies, today announced it has received written feedback from the U.S. Food and Drug ...

And good afternoon, and welcome everyone to the Relmada Therapeutics, Inc. Third Quarter 2025 Conference Call. 2025 is ...

Are you cancer-aware?

Jonathan Wygant, VP at Veracyte (NASDAQ: VCYT ), executed a substantial insider sell on November 12, according to an SEC ...